# Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1

> **NCT00015028** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)**

## Conditions studied

- Opioid-Related Disorders
- Substance-Related Disorders

## Interventions

- **DRUG:** Buprenorphine/naloxone

## Key facts

- **NCT ID:** NCT00015028
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-11
- **Primary completion:** 1996-12
- **Final completion:** 1997-01
- **Target enrollment:** 0 (—)
- **Last updated:** 2017-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00015028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00015028, "Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00015028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*